Description |
DX-88, a novel Kunitz domain produced by phage display (a powerful method of generating novel binders to potentially therapeutic targets), is a potent and selective inhibitor of plasma kallikrein which demonstrates a useful efficacy/safety ratio in the treatment of acute attacks of HAE(Hereditary Angioedema).
|
